/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

RNA

Tag

Latest Stories

One Shot
4.18.24, 9:42 AM EDT on neoscope
New Vaccine Could Protect Against Any Strain of a Virus With One Shot
Life Outs
3.12.24, 9:11 AM EDT on futurism
Scientists Just Got Closer to Creating Artificial Life in the Lab
Hormonal Treatments
9.3.22, 9:01 AM EDT on neoscope
Scientists Say New Treatment May Improve Cognition for People With Down Syndrome
Bug Watch
10.4.19, 5:27 PM EDT on neoscope
Watch the First Video of a Virus Growing in Real-Time
Futurism
12.15.17, 11:19 AM EST on neoscope
DNA That Folds Like Origami Has Applications for Drug-Delivering Nanobots
Futurism
11.16.17, 1:54 PM EST on neoscope
A Cancer Vaccine Was Just Injected Into Its First Patient
Futurism
10.30.17, 3:07 PM EDT on neoscope
We Just Created an Artificial Code That Governs Viruses
Futurism
10.26.17, 2:12 PM EDT on neoscope
CRISPR Can Now Be Used to Edit Individual Bases
Futurism
10.24.17, 1:56 PM EDT on neoscope
Scientists Discovered a "Kill Switch" That Destroys Any Cancer Cell
Futurism
Updated 4.8.17, 10:37 AM EDT on futurism
These Species Can Recode Their Own Genetics
Futurism
Updated 1.23.17, 1:10 AM EST on futurism
This New Drug Could Combat the Ebola Virus in a Unique Way
Futurism
Updated 11.29.16, 9:03 AM EST on futurism
MIT Engineers Test Programmable RNA Vaccines
  • Previous
  • 1
  • 2
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.